Perrigo Schweiz AG
Perrigo Schweiz AG is a OTC and phyto company based in Zürich (Zurich) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 141 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | OTC and phyto |
|---|---|
| City | Zürich |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | 1979 |
| Employees | 11-50 |
| Parent group | Perrigo Company plc |
| Activity | Not available |
| Website | perrigo.com |
Medicines authorised in Switzerland
Perrigo Schweiz AG is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Cobantril | 36199 | D | P02CC01 | 1971-04-20 |
| Cobantril | 36200 | D | P02CC01 | 1971-05-07 |
| ellaOne | 62531 | B | - | 2012-12-20 |
| ellaOne 30 mg | 66920 | B | G03AD02 | 2018-12-14 |
| Fenivir | 53680 | D | D06BB06 | 1997-02-25 |
| Fenivir | 62647 | D | D06BB06 | 2012-11-08 |
| Fortalis Baume/Balsam | 11066 | D | M02AC | 1942-07-06 |
| Granufink Blase | 65189 | D | G04BD | 2015-08-31 |
| Granufink femina | 65193 | D | G04BX | 2015-08-31 |
| Granufink Prosta forte | 65135 | D | G04CX | 2015-08-31 |
| Norlevo 1.5 mg | 62876 | B | G03AD01 | 2013-12-18 |
Frequently asked questions
How many medicines does Perrigo Schweiz AG have authorised in Switzerland?
Perrigo Schweiz AG is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Perrigo Schweiz AG based?
The Swiss location recorded for Perrigo Schweiz AG is Zürich, Zurich.
Is Perrigo Schweiz AG a Swissmedic authorisation holder?
Yes. Perrigo Schweiz AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.